Neurofilament Medium Chain (NF-M), also known as NEFM, is a neuronal intermediate filament protein encoded by the [NEFM](/genes/nfm) gene on chromosome 8p21, adjacent to the NEFL gene. NF-M co-assembles with NF-L and NF-H to form the heteropolymer neurofilament network in large-diameter axons [@nixon1994].
NF-M plays a critical role in establishing and maintaining axonal caliber, which directly impacts nerve conduction velocity. It is one of the most phosphorylated neuronal proteins, with phosphorylation levels increasing during development and decreasing in certain disease states. NF-M is released into CSF and blood following axonal injury, serving as a biomarker for neurodegeneration [@julien1995].
Domain Structure
NF-M has the typical intermediate filament domain organization:
Head Domain (1-90)
N-terminal non-helical domain
Multiple serine phosphorylation sites
Regulates filament assembly and interactions
Central Rod Domain (91-424)
Alpha-helical coiled-coil region
Highly conserved across species
Dimer formation site
Contains repeat motifs
Tail Domain (425-916)
Long C-terminal tail domain (carries the M designation)
Lysine-serine-proline (KSP) repeat motifs
Extensive phosphorylation sites
Projects from filament surface to regulate spacing
Contains binding sites for other proteins
Normal Function in the Nervous System
Axonal Cytoskeleton
NF-M co-polymerizes with NF-L to form heterodimers
These dimerize to form tetramers, the building block of filaments
NF-M determines the spacing between neurofilament side chains
Critical for maintaining optimal axonal diameter
Phosphorylation Regulation
Phosphorylation of tail domain regulates filament spacing
Casein kinase II and MAP kinases are key kinases
Phosphorylation increases during development
Dephosphorylation facilitates transport
Axonal Transport
Neurofilaments are transported bidirectionally along microtubules
Phosphorylation state affects transport rates
Kinesin and dynein motors move neurofilaments
Proper transport is essential for axonal maintenance
Interactions
Forms heteropolymers with NF-L and NF-H
Binds to protein 4.1 in the axonal membrane
Associates with intermediate filament-associated proteins
Interacts with signaling proteins via phosphorylated tails
Role in Neurodegeneration
Biomarker for Axonal Injury
CSF NF-M elevated in ALS, PD, AD, and other neurodegenerative conditions
Blood NF-M can be detected with sensitive assays
Often measured alongside NF-L for comprehensive assessment
Reflects the extent of axonal damage
Disease Involvement
Neurofilament accumulation in swollen axons is a hallmark of many neurodegenerative diseases
Abnormal phosphorylation patterns in disease states
NF-M fragmentation detected in affected brain regions
Mutations in NEFM cause axonal neuropathy
Transport Defects
Impaired axonal transport contributes to neurofilament accumulation
Abnormal aggregation in axonal spheroids
Seen in ALS, Charcot-Marie-Tooth disease, and experimental models
Therapeutic Relevance
NF-M as biomarker in clinical trials
Targeting phosphorylation pathways to improve transport
Gene therapy approaches for NEFM mutations
Therapeutic Targeting
Biomarker Applications
NF-L and NF-M together provide more comprehensive axonal damage assessment
Used in clinical trials for ALS, PD, and AD
Helps monitor disease progression and treatment response
Predictive of clinical outcomes
Research Directions
Develop inhibitors of neurofilament-aggregating pathways
Gene therapy for NEFM-linked neuropathies
Small molecules to improve neurofilament phosphorylation dynamics
Immunotherapy to reduce neurofilament levels
Key Publications
[Nixon et al., Neurofilament expression in human brain and neurodegenerative disease (1994)](https://pubmed.ncbi.nlm.nih.gov/8035208/). Journal of Comparative Neurology. 1994;347(1):1-16.
[Julien et al., Neurofilament proteins in neurodegeneration (1995)](https://pubmed.ncbi.nlm.nih.gov/7643172/). Progress in Brain Research. 1995;105:325-333.
[Lee et al., Neurofilament phosphorylation in neuronal development and disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24727566/). Experimental Neurology. 2014;253:71-81.
Nixon RA, et al, Neurofilament expression in human brain and neurodegenerative disease (1994)
Julien JP, et al, Neurofilament proteins in neurodegeneration (1995)
Lee MJ, et al, Neurofilament phosphorylation in neuronal development and disease (2014)
Pathway Diagram
The following diagram shows the key molecular relationships involving Neurofilament Medium Chain (NF-M) discovered through SciDEX knowledge graph analysis: